Neurocrine Biosciences, Inc.

NasdaqGS:NBIX Stock Report

Market Cap: US$13.5b

Neurocrine Biosciences, Inc. Company Information

Neurocrine Biosciences, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Neurocrine Biosciences, Inc.
  • Ticker: NBIX
  • Exchange: NasdaqGS
  • Founded: 1992
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$13.544b
  • Shares Outstanding: 100.58m
  • Website: https://www.neurocrine.com

Number of Employees


Location

  • Neurocrine Biosciences, Inc.
  • 12780 El Camino Real
  • San Diego
  • California
  • 92130
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NBIXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDMay 1996
NB3DB (Deutsche Boerse AG)YesCommon StockDEEURMay 1996
0K6RLSE (London Stock Exchange)YesCommon StockGBUSDMay 1996
N1BI34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 20 REPR 1 COM NPVBRBRLOct 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/15 00:00
End of Day Share Price 2024/04/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.